Table 1.
Liver promoter/enhancer containing genes employed in the study.
| Gene | Chr | Expa | Pr/Enh Lengthb |
Gene | Chr | Exp | Prom/Enh length |
|---|---|---|---|---|---|---|---|
| NR0B2 | 1 | 40.9 | 7024 | SLCO1B3 | 12 | 32.6 | 367 |
| CYP4A11 | 1 | 155.0 | 2942 | AMDHD1 | 12 | 46.0 | 2355 |
| C8A | 1 | 175.8 | 4210 | NR1H4 | 12 | 24.3 | 13271 |
| F5 | 1 | 21.5 | 9132 | MIA2 | 14 | 1.1 | 3267 |
| C4BPA | 1 | 262.8 | 848 | LINC01146 | 14 | 5.3 | 113 |
| PROX1 | 1 | 18.8 | 10345 | ASPG | 14 | 59.8 | 5005 |
| AGT | 1 | 630.3 | 2560 | PCSK6 | 15 | 64.1 | 16783 |
| APOB | 2 | 206.5 | 2623 | ACSM5 | 16 | 64.4 | 3426 |
| FABP1 | 2 | 469.8 | 6721 | CES1 | 16 | 223.0 | 1371 |
| ABCB11 | 2 | 6.5 | 6310 | CA5A | 16 | 15.5 | 3170 |
| MOGAT1 | 2 | 1.4 | 3313 | SERPINF2 | 17 | 669.0 | 3747 |
| C2orf72 | 2 | 60.5 | 4072 | TM4SF5 | 17 | 66.9 | 3086 |
| RAB17 | 2 | 59.4 | 10699 | SLC13A5 | 17 | 163.4 | 3825 |
| ITIH1 | 3 | 329.0 | 2342 | ASGR2 | 17 | 232.2 | 4103 |
| NR1I2 | 3 | 23.8 | 8604 | PIPOX | 17 | 81.8 | 25025 |
| UROC1 | 3 | 47.4 | 1171 | ENPP7 | 17 | 2.3 | 9837 |
| SLC2A2 | 3 | 88.8 | 16823 | TMEM105 | 17 | 0.7 | 11323 |
| FETUB | 3 | 29.9 | 1100 | TTR | 18 | 1516.9 | 706 |
| KLB | 4 | 5.1 | 1682 | ONECUT2 | 18 | 2.6 | 16026 |
| F11 | 4 | 47.8 | 2781 | LRG1 | 19 | 463.4 | 6659 |
| AGXT2 | 5 | 34.9 | 3262 | TNFSF14 | 19 | 27.8 | 3870 |
| ACOT12 | 5 | 23.2 | 1200 | C3 | 19 | 1009.1 | 6411 |
| IGFBP1 | 7 | 198.9 | 2430 | PALM3 | 19 | 21.0 | 4458 |
| MLXIPL | 7 | 244.9 | 2644 | CYP4F3 | 19 | 76.1 | 3318 |
| ABCB4 | 7 | 18.1 | 3044 | HPN | 19 | 275.0 | 3243 |
| PON3 | 7 | 83.7 | 2259 | FOXA3 | 19 | 19.1 | 5686 |
| AKR1D1 | 7 | 31.3 | 21240 | SULT2A1 | 19 | 241.9 | 2677 |
| FGL1 | 8 | 848.6 | 5244 | LINC00261 | 20 | 38.7 | 6145 |
| ADRA1A | 8 | 8.4 | 1952 | HNF4A | 20 | 43.9 | 50902 |
| GAS2 | 11 | 5.0 | 11464 | SEC14L4 | 22 | 8.7 | 1522 |
| OTC | 23 | 34.4 | 8346 |
a
Gene expression in RPKM.
b
Total Promoter/Enhancer length in gene (bp).